TABLE 4.
Malignant sputum N = 8 | Liquid specimens (sputum cfDNA) | ||||||
---|---|---|---|---|---|---|---|
p.T790 M Mutation | Positive | Negative | Sensitivity % (95% CI) | Specificity % (95% CI) | PPV % (95% CI) | NPV% (95% CI) | |
Matched tumor sample | Positive | 4 | 0 | 100% (39.6%, 100%) | 100% (39.6%, 100%) | 100% (39.6%, 100%) | 100% (39.6%, 100%) |
Negative | 0 | 4 | |||||
Satisfactory but no malignant cells sputum N = 10 | Liquid specimens (sputum cfDNA +plasma cfDNA) | ||||||
p.T790 M Mutation | Positive | Negative | Sensitivity % (95% CI) | Specificity % (95% CI) | PPV % (95% CI) | NPV % (95% CI) | |
Matched tumor sample | Positive | 3 | 0 | 100% (31.0%, 100%) | 100% (56.1%, 100%) | 100% (31.0%, 100%) | 100% (56.1%, 100%) |
Negative | 0 | 7 | |||||
Unsatisfactory sputum N = 3 | Liquid specimens (plasma cfDNA) a | ||||||
p.T790 M Mutation | Positive | Negative | Sensitivity % (95% CI) | Specificity % (95% CI) | PPV % (95% CI) | NPV % (95% CI) | |
Matched tumor sample | Positive | 1 | 1 | 50% (2.7%, 97.3%) | 100% (5.5%, 100%) | 100% (5.5%, 100%) | 50% (2.7%, 97.3%) |
Negative | 0 | 1 |
The plasma samples of two cases were unavailable.